Based on the Aspen Pharmacare Holdings Ltd ADR stock forecast from 0 analysts, the average analyst target price for Aspen Pharmacare Holdings Ltd ADR is not available over the next 12 months. Aspen Pharmacare Holdings Ltd ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aspen Pharmacare Holdings Ltd ADR is Neutral, which is based on 2 positive signals and 2 negative signals. At the last closing, Aspen Pharmacare Holdings Ltd ADR’s stock price was USD 6.38. Aspen Pharmacare Holdings Ltd ADR’s stock price has changed by -24.59% over the past week, -30.50% over the past month and -43.49% over the last year.
No recent analyst target price found for Aspen Pharmacare Holdings Ltd ADR
No recent average analyst rating found for Aspen Pharmacare Holdings Ltd ADR
Company Overview Aspen Pharmacare Holdings Ltd ADR
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Aspen Pharmacare Holdings Ltd ADR (APNHY)
Loading...
Unadjusted Closing Price for Aspen Pharmacare Holdings Ltd ADR (APNHY)
Loading...
Share Trading Volume for Aspen Pharmacare Holdings Ltd ADR Shares
Loading...
Compare Performance of Aspen Pharmacare Holdings Ltd ADR Shares
Stock Target Advisor's fundamental analysis for Aspen Pharmacare Holdings Ltd ADR's stock is Neutral.
Unfortunately we do not have enough data on APNHY's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on APNHY's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on APNHY's stock to indicate if its overvalued.
The last closing price of APNHY's stock was USD 6.38.
Unfortunately we do not currently have any market capitalization data for APNHY's stock.
Unfortunately we do not have enough analyst data on APNHY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aspen Pharmacare Holdings Ltd ADR's stock.
Sorry, we do not have any data on the number of employees for Aspen Pharmacare Holdings Ltd ADR.
Sorry we do not have any infomation available on Aspen Pharmacare Holdings Ltd ADR's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
